Phlexglobal

Sector Healthcare
Location London
Date acquired 2014
Transaction size Not disclosed

A specialist provider of technology-enabled document management solutions and other support services to the global clinical research market


In December 2016, Phlexglobal was acquired by Vitruvian Partners.

This investment was made by Bridgepoint Development Capital.

To learn more about the company, click here.

Established in 1997, Phlexglobal's Trial Master File (‘TMF’) software and services support the administrative and operational aspects of the pharmaceutical clinical trial process. A TMF is required by law and demonstrates compliance with regulatory standards for the conduct of a clinical trial.

Bridgepoint’s investment supported Phlexglobal’s existing management to deliver the geographical and strategic growth that they are seeking to achieve, including an increasing emphasis on technology-led electronic TMF solutions.

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.